Harpoon Therapeutics
Harpoon Therapeutics

Revolutionizing mRNA: A Breakthrough in Biologics!
🌟 Discover how Ginkgo Bioworks and TriLink BioTechnologies are revolutionizing mRNA manufacturing for better vaccines and therapeutics! 🚀🔬💡

Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!
📢 German CDMO Wacker Biotech opens €100m RNA manufacturing site, creating 100 jobs and expanding expertise in RNA active ingredients. 💪🌍

Revolutionizing Biomanufacturing: Faster Cheaper and More Efficient
🧪 Quick production of therapeutics and vaccines using a disease-agnostic platform approach. 📊 Improved mRNA yields in just two hours. 🖥️ Real-time process monitoring and control. 💉 Billions of vaccine doses produced using a platform process. 🧫 Efficient and cost-effective allogeneic cell therapies. 🌐 Scalable, monitored, and controlled manufacturing of advanced therapies and vaccines. 💡 Future perspective: reducing costs and manufacturing risk with platform-based iPSC production.

Merck Acquiring Harpoon for $680M: Revolutionizing Cancer Treatment!
📰 Merck buys Harpoon Therapeutics for $680m, boosting its cancer treatment capabilities. 💊💉 Exciting move in immuno-oncology! 🌟👨🔬🚀






